GlassScriptPhysician profile
Mark F Sherman
NPI 1407819741
$65,124.82
in general payments reported to CMS, 2019-2025
13 companies · $65K in 2025
The $65K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.59 · 2020: $154 · 2021: $85.03 · 2022: $81.52 · 2023: $187 · 2025: $65K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $65K · Food and Beverage: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $64,500.00 |
| Food and Beverage | $204.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $64,500.00 | 2025 | |
| Depuy Synthes Sales INC. | $152.22 | 2019-2023 | Monovisc |
| Linvatec Corporation | $126.06 | 2023 | Livatec Knee Preservation System |
| Anika Therapeutics, INC. | $103.95 | 2020 | |
| Ferring Pharmaceuticals INC. | $65.67 | 2020-2022 | |
| Arthrex, INC. | $45.43 | 2023 | |
| Pacira Therapeutics, INC. | $39.12 | 2021 | |
| Fidia Pharma USA INC. | $18.18 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $17.75 | 2025 | |
| Gotham Surgical Solutions & Devices, INC. | $17.31 | 2019 | |
| Dexcom, INC. | $14.88 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $12.84 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Sherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.